Harvest Volatility Management LLC Vertex Pharmaceuticals Inc Transaction History

Harvest Volatility Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $408,431 - $457,131	-1,299 Reduced 14.06%	7,937 $2.79 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $452,601 - $516,313	-1,598 Reduced 14.75%	9,236 $2.91 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $790,697 - $889,535	-2,767 Reduced 20.34%	10,834 $3.13 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $65,719 - $73,327	-240 Reduced 1.73%	13,601 $3.98 Million
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $391,443 - $487,388	-1,666 Reduced 10.74%	13,841 $3.9 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $1,992 - $2,348	-9 Reduced 0.06%	15,507 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $632,456 - $798,386	3,573 Added 29.92%	15,516 $3.41 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $819,520 - $917,108	4,518 Added 60.85%	11,943 $2.17 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $334,482 - $394,442	1,784 Added 31.63%	7,425 $1.5 Million
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $446,128 - $520,023	2,155 Added 61.82%	5,641 $1.21 Million
Q4 2020 Mar 08, 2021	BUY	$207.01 - $276.09 $721,636 - $962,449	3,486 New	3,486 $824,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Harvest Volatility Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Volatility Management LLC with notifications on news.